explore -WSS

explore

author：knowledge 2025-09-06 04:13:57 - browse：3

This image provided by Novo Nordisk in January 2023, shows packaging for the company's Wegovy drug. — Novo Nordisk via AP

PHILADELPHIA — Novo Nordisk’s obesity drug Wegovy notably cut the risk of heart attacks in a landmark cardiovascular trial that affirms the treatment offers health benefits beyond weight loss.

The company in August had announced that in this trial, called Select, Wegovy reduced the overall rate of major heart problems — heart attacks, stroke, or cardiovascular-related death — by 20%. That finding, which was the primary outcome the trial set out to study, was stronger than many were expecting and led Novo’s stock to surge.

But details of the study, including risk reductions for each specific heart complication, were not released until Saturday, when they were presented here — before a standing-room only crowd — as the first major session of the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Superbugs, antibiotic resistance get scrutiny in congress

WSS

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

After half a century, Israel moves to evict squatter from his cave home on the beach

Tornado touches down near Chicago's O'Hare airport amid extreme weather nationwide

Is there an 'orca uprising'? Like orcas themselves, the answer is complex.

Biden launches a new push to limit health care costs

Study: Pain burden is higher in Black NFL players than white ones

entertainment

explore

hotspot

Hepatitis C has a cure — but many Americans still lack access to it

NIH fellows want a pay raise. Will that mean less money for grants?

Guidelines to prevent youth baseball injuries need more muscle

Is there an 'orca uprising'? Like orcas themselves, the answer is complex.

23andMe had bad news about my health. I wish a person had delivered it

How are insurers handling Leqembi and related scans?

Duchenne breakthrough therapy leaves behind pioneering families

New research casts further doubt on a common procedure used with IVF

Sports medicine is finally prioritizing gender equality

How the political right came to back psychedelics to treat trauma

entertainment

Digital health funding stays low as a new reality sets in

Antibody drugs appear effective. Now can we make enough of them?

Why ADHD is under

Dozens of Pride flags vandalized at Stonewall monument in NYC, 3rd time this month: Police

A Greenpeace activist is fined for crash

Kerry to visit Beijing for climate talks amid efforts to revive relations between US and China

focus

Wikipedia

Wikipedia

focus